Table 3.
Enterobacterales (see also Supplementary Table S1) | Lac 1 | Ind 1 | Cit 1 | VP 1 | Ure 1 | Mot 1 | H2S 1 | LDC 1 | Nit 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Escherichia coli | + | + | – | – | – | + | – | + | + | |
Klebsiella pneumoniae | + | – | + | + | + | – | – | + | + | |
Klebsiella oxytoca | + | + | + | + | + | – | – | + | + | |
Enterobacter cloacae | + | – | + | + | V | + | – | – | + | |
Enterobacter aerogenes | + | – | + | + | – | + | – | + | + | |
Citrobacter freundii | V | – | + | – | V | + | (+) | – | + | |
Citrobacter koseri | V | + | + | – | V | + | – | – | + | |
Proteus mirabilis | – | – | V | V | + | + | + | – | + | |
Proteus vulgaris | – | + | (–) | – | + | + | + | – | + | |
Providencia stuartii | – | + | + | – | V | (+) | – | – | + | |
Morganella morganii | – | + | – | – | + | + | – | – | + | |
Serratia marcescens | – | – | + | + | (–) | + | – | + | + | |
Glucose-non-
fermenting Gram-negative rods |
Oxi 1 | Lac 1 | Ind 1 | Cit 1 | VP 1 | Ure 1 | Mot 1 | H2S 1 | LDC 1 | Nit 1 |
Pseudomonas aeruginosa | + | - | - | V | - | (-) | + | - | - | V |
Acinetobacter baumannii | - | - | - | + | - | - | - | - | - | - |
Staphylococci (catalase-positive) | Slide Agg 1 | Tube Coag 1 | Hemolysis | Salt Tol 1 | Mann 1 | Nov 1 | ||||
Staphylococcus aureus | + | + | V | + | + | S | ||||
Staphylococcus saprophyticus | - | - | None * | + | + * or - | R | ||||
Staphylococcus epidermidis group | - | - | None * | + | - | S | ||||
Streptococci (catalase-negative) | Lanc 1 | Hemolysis | Bile esc 1 | 6.5% NaCl tol 1 | ||||||
Enterococci | D | No hemolysis * | + | + | ||||||
Group D streptococci other than enterococci | D | β-, α-, or no hemolysis | + | - | ||||||
Streptococcus agalactiae | B | β-hemolysis * | - | - |
1 Lac, lactose fermentation; Ind, indole; Cit, citrate utilization; VP, Voges-Proskauer; Ure, urease; Mot, motility; H2S, hydrogen sulfide production; LDC, lysine decarboxylase; Nit, nitrates reduction; Oxi, oxidase; Agg, agglutination; Coag, coagulase; Tol, tolerance; Mann, mannitol fermentation; Nov, novobiocin susceptibility; Bile esc, bile esculin hydrolysis; +, 90–100% Positive; -, 0–10% positive; (+), 76–89% positive; (-), 11–25% positive; V, variable.* Most strains.